# Brighthouse Financial, Inc.: overview

BHF · Nasdaq · CIK 1685040 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhf.md) · [Financials](/companies/bhf/financials.md) · [Filings](/companies/bhf/filings.md) · [Insiders](/companies/bhf/insiders.md)

Latest reported revenue: [$1.62bn](/filings/0001685040-26-000028.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001685040-26-000028).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,018](/filings/0001685040-25-000071.md) | [1,205 d](/filings/0001685040-26-000011.md) | [2,390](/filings/0001685040-26-000019.md) | [871](/filings/0001685040-26-000028.md) | [1,816](/filings/0001685040-25-000071.md) | [1,689 d](/filings/0001685040-26-000011.md) | [1,527](/filings/0001685040-26-000019.md) | [1,622](/filings/0001685040-26-000028.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.7%](/filings/0001685040-25-000071.md) | [55.7% d](/filings/0001685040-26-000011.md) | [(11.2%)](/filings/0001685040-26-000019.md) | [9.8%](/filings/0001685040-26-000028.md) | [26.4%](/filings/0001685040-25-000071.md) | [8.1% d](/filings/0001685040-26-000011.md) | [(50.2%)](/filings/0001685040-26-000019.md) | [60.5%](/filings/0001685040-26-000028.md) |
| Diluted EPS | $ per share | [2.47](/filings/0001685040-25-000071.md) | not reported | [(5.04)](/filings/0001685040-26-000019.md) | [1.02](/filings/0001685040-26-000028.md) | [7.89](/filings/0001685040-25-000071.md) | not reported | [(13.82)](/filings/0001685040-26-000019.md) | [16.53](/filings/0001685040-26-000028.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,976](/filings/0001685040-24-000007.md) | [6,873](/filings/0001685040-25-000010.md) | [4,117](/filings/0001685040-26-000011.md) | [4,724](/filings/0001685040-26-000011.md) | [6,766](/filings/0001685040-26-000011.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [33.0%](/filings/0001685040-24-000007.md) | [56.4%](/filings/0001685040-25-000010.md) | [(27.0%)](/filings/0001685040-26-000011.md) | [8.2%](/filings/0001685040-26-000011.md) | [6.4%](/filings/0001685040-26-000011.md) |
| Diluted EPS | $ per share | [18.39](/filings/0001685040-24-000007.md) | [51.30](/filings/0001685040-25-000010.md) | [(18.39)](/filings/0001685040-26-000011.md) | [4.64](/filings/0001685040-26-000011.md) | [5.71](/filings/0001685040-26-000011.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bhf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $341.4m | 5,393,709 |  | Added +120,769 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $265.9m | 4,200,939 |  | Added +466,463 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $230.1m | 3,634,379 |  | Added +78,556 |
| [DME Capital Management, LP](/funds/1489933.md) | 2026-06-30 | $179.9m | 2,842,100 |  | Unchanged |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $168.0m | 2,653,810 |  | Added +61,405 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $164.4m | 2,596,834 |  | Added +27,160 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $157.7m | 2,491,401 |  | Reduced −7,663 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $131.8m | 2,082,421 |  | Added +143,523 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $118.9m | 1,878,445 |  | Added +591,209 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $77.1m | 1,218,367 |  | Reduced −307,891 |

## Recent filings

[All 588 filings](/companies/bhf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-18 | 16:22 ET | [8-K](/filings/0001685040-26-000031.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001685040-26-000031 |
| 2026-08-06 | 16:12 ET | [10-Q](/filings/0001685040-26-000028.md) | Quarterly report, period 2026-06-30 | 0001685040-26-000028 |
| 2026-08-05 | 16:21 ET | [8-K](/filings/0001685040-26-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001685040-26-000026 |
| 2026-06-03 | 16:14 ET | [8-K](/filings/0001685040-26-000022.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001685040-26-000022 |
| 2026-05-07 | 16:36 ET | [10-Q](/filings/0001685040-26-000019.md) | Quarterly report, period 2026-03-31 | 0001685040-26-000019 |
| 2026-05-06 | 16:23 ET | [8-K](/filings/0001685040-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001685040-26-000017 |
| 2026-04-14 | 16:27 ET | [DEF 14A](/filings/0001193125-26-154952.md) | Proxy statement, period 2026-06-02 | 0001193125-26-154952 |
| 2026-02-24 | 17:13 ET | [10-K](/filings/0001685040-26-000011.md) | Annual report, period 2025-12-31 | 0001685040-26-000011 |
| 2026-02-23 | 16:25 ET | [8-K](/filings/0001685040-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001685040-26-000009 |
| 2026-02-12 | 16:21 ET | [8-K](/filings/0001685040-26-000005.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001685040-26-000005 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001685040-26-000011.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a6f44487-b407-4b51-a6e3-836e8cfd4305)

## About the filer

- CIK: 1685040
- Tickers: BHF, BHFAL, BHFAM, BHFAN, BHFAO, BHFAP
- Exchange: Nasdaq
- SIC code: 6311 Life Insurance
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.
